MMRV vaccine booster in pregnant adults in Alberta
Part of Immune system & allergy clinical trials.
This study looks at whether getting a third dose of the MMRV vaccine during pregnancy is helpful. It focuses on pregnant women who were screened for rubella immunity during routine prenatal testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant
- You are age 18 or older
- You had routine prenatal blood testing for rubella antibodies
- The study is only for women (not for anyone who is not a woman)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This study tests whether a second dose of the RSV vaccine during a new pregnancy protects you and your baby from RSV. If you received the RSVpreF or Abrysvo vaccine in a past pregnancy, you may be able to join.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
This study looks at how well the RSV vaccine given to pregnant women (called ABRYSVO) protects babies from getting RSV after birth. It uses national health data from Scotland to track health outcomes.
This study tests a vaccine (called RSVpreF) for pregnant people living with HIV. The vaccine is meant to boost your own immunity so you can pass protection to your baby against RSV, a common and sometimes dangerous respiratory infection.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
Hear when a new Vaccine Response Impaired trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.